Dual-Epigenetic CHOP Misses PTCL Endpoints
A peer-reviewed multicenter phase 3 study from China compared azacitidine plus chidamide and CHOP with CHOP alone in 128 previously untreated patients with peripheral T-cell lymphoma. The experimental regimen did not significantly improve overall…
